Eliot Chadwick

Eliot Chadwick

Auto-generated profile, based on publicly available information

Eliot Chadwick

Nottingham City Hospital, Nottingham, England, United Kingdom

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
FSFinbar Slevin
Finbar Slevin
KAKatharine L. Aitken
Katharine L. Aitken
Filippo AlongiFilippo Alongi
Filippo Alongi
SASTEFANO ARCANGELI
STEFANO ARCANGELI
ECEliot Chadwick
Eliot Chadwick
LMLouise Murray
Louise Murray

19 August 2011 in BJU International
Verified
Journal Article
Closed access
PDF file
AEAmr M. Emara
Amr M. Emara
ECEliot Chadwick
Eliot Chadwick
JNJenny P. Nobes
Jenny P. Nobes
AAAther Mohamed Abdelbaky
Ather Mohamed Abdelbaky
RLRobert W. Laing
Robert W. Laing
SLStephen E.M. Langley
Stephen E.M. Langley

11 January 2023 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
JSJacqueline Steinke
Jacqueline Steinke
CJChloe Jordan
Chloe Jordan
SRSavvas Rossides
Savvas Rossides
HMHelen Minnaar
Helen Minnaar
JYJimmy Yu
Jimmy Yu
ASAlexandra J. Stewart
Alexandra J. Stewart
The use of external beam radiotherapy (EBRT) and contact X-Ray brachytherapy (CXB) is emerging as an effective alternative in patients with early stage rectal cancer with the intent of organ preservation (OP). Short course radiotherapy (SCRT) is an alternative EBRT schedule for patients not fit for chemotherapy or for longer courses of EBRT. There are no multicentre studies that have reported on the outcomes of SCRT with a CXB boost, therefore we present these from patients from centres from the UK and Sweden. From the Guildford Colorectal Database or local databases, 258 patients who underwent SCRT and CXB with the intent of OP from five centres treated between 2007 and 2019 were identified. Response and survival data was analysed and presented. With a median age of 81, 226 patients were treated with radiotherapy alone (RTA) and 32 immediately after local excision (ILE). Median follow-up was 24 months. 70% and 97% of patients in the RTA and ILE groups respectively had a complete clinical response (cCR) after SCRT with CXB. Of those, local relapse was seen in 16% of the RTA and 3% of the ILE group. Median survival was 40 months after CXB in the RTA and 52 months in the ILE group. 94% of patients remained stoma-free to the point of latest follow-up. This data suggests that CXB when combined with SCRT, in a mainly elderly and comorbid population, provides good palliation with stoma-avoidance. Oncological outcomes compare with previously published work. A greater focus is required on quality of life outcomes after OP.

1 February 2012 in European Urology Supplements
Verified
Journal Article
Closed access
Saqib JavedSaqib Javed
Saqib Javed
BJB. John
B. John
ECE. Chadwick
E. Chadwick
BMB. Montgomery
B. Montgomery
SBS. Bott
S. Bott
SLS. Langley
S. Langley

1 February 2012 in European Urology Supplements
Verified
Journal Article
Closed access
ECE. Chadwick
E. Chadwick
SJS. Javed
S. Javed
RLR.W. Laing
R.W. Laing
SLS.E.M. Langley
S.E.M. Langley

1 March 2013 in European Urology Supplements
Verified
Journal Article
Closed access
Saqib JavedSaqib Javed
Saqib Javed
ECE. Chadwick
E. Chadwick
SBS. Beveridge
S. Beveridge
SBS. Bott
S. Bott
CEC. Eden
C. Eden
SLS. Langley
S. Langley